{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:41:21Z","timestamp":1785526881815,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jacl.2014.09.014","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T20:25:52Z","timestamp":1412540752000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency"],"prefix":"10.1016","volume":"9","author":[{"given":"Andreas G.","family":"Moraitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lita A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Shamburek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Demosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth G.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalrahman","family":"Zarzour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Pucino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Csako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Yarboro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Koneti","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Illei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2014.09.014_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: A consensus statement from the National Lipid Association","volume":"7","author":"Toth","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2014.09.014_bib2","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2012-2185","article-title":"Approach to the patient with extremely low HDL-cholesterol","volume":"97","author":"Rader","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2014.09.014_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacl.2007.02.003","article-title":"Severe acquired (secondary) high-density lipoprotein deficiency","volume":"1","author":"Goldberg","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2014.09.014_bib4","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jacl.2014.09.014_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: The impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacl.2014.09.014_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.autrev.2007.11.016","article-title":"Systemic lupus erythematosus and \u201clupus dyslipoproteinemia\u201d","volume":"7","author":"de Carvalho","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jacl.2014.09.014_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2014.09.014_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2011.661","article-title":"Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-hodgkin lymphoma","volume":"172","author":"Simonelli","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2014.09.014_bib9","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.4049\/jimmunol.167.7.4075","article-title":"Il-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis","volume":"167","author":"McInnes","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.jacl.2014.09.014_bib10","series-title":"Lipoproteins and cardiovascular disease: Methods and protocols. Methods Mol Biol","first-page":"343","article-title":"Measurement of lecithin-cholesterol acyltransferase activity with the use of a peptide-proteoliposome substrate","author":"Vaisman","year":"2013"},{"key":"10.1016\/j.jacl.2014.09.014_bib11","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH international workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jacl.2014.09.014_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacl.2014.09.014_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering FAS gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jacl.2014.09.014_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI115867","article-title":"A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease","volume":"90","author":"Sneller","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2014.09.014_bib15","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2169\/internalmedicine.46.0206","article-title":"Intravascular lymphoma with extremely low high-density lipoproteinemia","volume":"46","author":"Ohashi","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jacl.2014.09.014_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/SMJ.0b013e3181fcd4b9","article-title":"Disseminated intravascular large B cell lymphoma with slowly decreasing high-density lipoprotein cholesterol","volume":"104","author":"Garg","year":"2011","journal-title":"South Med J"},{"key":"10.1016\/j.jacl.2014.09.014_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.1993.tb00674.x","article-title":"The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma","volume":"233","author":"Blackman","year":"1993","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacl.2014.09.014_bib18","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"Fas-l, IL-10, and double-negative CD4- CD8- TCR alpha\/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with fas loss of function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jacl.2014.09.014_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","article-title":"Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome","volume":"125","author":"Caminha","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacl.2008.06.002","article-title":"Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states","volume":"2","author":"Santos","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2014.09.014_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0b013e3283468061","article-title":"Metabolic and functional relevance of HDL subspecies","volume":"22","author":"Asztalos","year":"2011","journal-title":"Curr Opin Lipidol"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2014.09.014_bib22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"Il-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jacl.2014.09.014_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/08830185.2012.762361","article-title":"IL-10-producing lymphocytes in inflammatory disease","volume":"32","author":"Yao","year":"2013","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy\u2013review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jacl.2014.09.014_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00262-011-1104-5","article-title":"Dual biological effects of the cytokines interleukin-10 and interferon-gamma","volume":"60","author":"Wilke","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jacl.2014.09.014_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2013.00018","article-title":"Pro-inflammatory signaling by IL-10 and IL-22: Bad habit stirred up by interferons?","volume":"4","author":"Muhl","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-3024.2009.01187.x","article-title":"Plasma lipoproteins in visceral leishmaniasis and their effect on leishmania-infected macrophages","volume":"32","author":"Soares","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","article-title":"Changes in lipid levels with inflammation and therapy in RA: A maturing paradigm","volume":"9","author":"Robertson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jacl.2014.09.014_bib31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00003246-200108000-00011","article-title":"Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients","volume":"29","author":"Gordon","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacl.2014.09.014_bib32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/80.13.1039","article-title":"Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study","volume":"80","author":"Spriggs","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jacl.2014.09.014_bib33","series-title":"The HDL Handbook (Second Edition) Biological Functions and Clinical Implications","first-page":"159","article-title":"Role of lecithin: Cholesterol acyltransferase in HDL metabolism and atherosclerosis","author":"Ahsan","year":"2014"},{"key":"10.1016\/j.jacl.2014.09.014_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0005-2760(88)90168-3","article-title":"Cholesterol esterification by lecithin-cholesterol acyltransferase in A-I-free plasma","volume":"962","author":"Cheung","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2014.09.014_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005072-197803000-00003","article-title":"Biochemical studies in a patient with a Tangier syndrome","volume":"37","author":"Yao","year":"1978","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jacl.2014.09.014_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1194\/jlr.M700362-JLR200","article-title":"Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency","volume":"49","author":"Santos","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2014.09.014_bib37","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/sj.gt.3302348","article-title":"Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice","volume":"11","author":"Yoshioka","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.jacl.2014.09.014_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.gene.6364144","article-title":"Is there an interaction between interleukin-10 and interleukin-22?","volume":"6","author":"Wolk","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.jacl.2014.09.014_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2362.1999.00410.x","article-title":"Lack of interleukin 10 regulation of antigen presentation-associated molecules expressed on colonic epithelial cells","volume":"29","author":"Bourreille","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacl.2014.09.014_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/intimm\/12.2.133","article-title":"Expression of IL-10 receptors on epithelial cells from the murine small and large intestine","volume":"12","author":"Denning","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.jacl.2014.09.014_bib41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cyto.2013.01.012","article-title":"Il-10 modulates serotonin transporter activity and molecular expression in intestinal epithelial cells","volume":"61","author":"Latorre","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jacl.2014.09.014_bib42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0016-5085(82)80132-7","article-title":"Apolipoprotein localization and quantitation in the human intestine","volume":"83","author":"Green","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2014.09.014_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI111676","article-title":"Isolation of high density lipoproteins from rat intestinal epithelial cells","volume":"75","author":"Magun","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2014.09.014_bib44","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI119363","article-title":"Intestinal transcription and synthesis of apolipoprotein A-I is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene","volume":"99","author":"Naganawa","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacl.2014.09.014_bib45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.19.3.611","article-title":"Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death","volume":"19","author":"Mallat","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2014.09.014_bib46","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","article-title":"Protective role of interleukin-10 in atherosclerosis","volume":"85","author":"Mallat","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2014.09.014_bib47","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1161\/01.ATV.19.12.2847","article-title":"Interleukin-10 blocks atherosclerotic events in\u00a0vitro and in\u00a0vivo","volume":"19","author":"Pinderski Oslund","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2014.09.014_bib48","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2014.09.014_bib49","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1096\/fj.09-148155","article-title":"Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice","volume":"24","author":"Han","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.jacl.2014.09.014_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-5273(03)00084-6","article-title":"Anti-inflammatory cytokine profile in acute coronary syndromes: Behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines","volume":"92","author":"Tziakas","year":"2003","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.014_bib51","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/hrt.2007.119271","article-title":"Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome","volume":"94","author":"Malarstig","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2014.09.014_bib52","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/ATVBAHA.111.231795","article-title":"Circulating interleukin-10 and risk of cardiovascular events: A prospective study in the elderly at risk","volume":"31","author":"Welsh","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414003389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414003389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T11:54:29Z","timestamp":1598356469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287414003389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1933287414003389"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2014.09.014","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2014.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}